Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.1
4.9
Journals
IJMS
Special Issues
Primary Mitochondrial Diseases and Secondary Mitochondrial Dysfunction: New Insights and...
ijms-logo
Submit to IJMS Review for IJMS Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Primary Mitochondrial Diseases and Secondary Mitochondrial Dysfunction: New Insights and Therapies

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (20 September 2023) | Viewed by 4353

Special Issue Editor

Prof. Dr. Konstantin Belosludtsev

E-Mail Website
Guest Editor
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskaya 3, 142290 Pushchino, Russia
Interests: mitochondria; biophysics; diabetes mellitus; myopathy; mitochondrial Ca2+ transport; permeability transition pore; oxidative stress; reactive oxygen species; lipids; membrane proteins; liposomes
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

New developments in the field of genetic methodology and molecular techniques have allowed us to recognize mitochondrial disorders as more complex and multifactorial than originally thought. At present, the terms “primary mitochondrial disease” and “secondary mitochondrial dysfunction” have been widely used to characterize mitochondrial pathophysiology. Primary mitochondrial diseases are clinically heterogeneous diseases associated with changes in genetic material (e.g., deletions, depletions, mutations) within the DNA of mitochondria (mtDNA) or cell nuclei (nDNA), affecting mainly nervous and muscular tissues. Beyond the disorders recognized as mitochondrial diseases, abnormalities in the ultrastructure and function of mitochondria in cells have been revealed in a number of unrelated pathologies. These include diabetes mellitus, cardiovascular pathologies, myopathies, cancers, organ-specific (e.g., eye or liver) disorders, ageing, as well as neurologic and immune diseases. In addition, multiple lines of evidence have suggested mitochondrial dysfunction as a mechanism for pharmaceutical-drug-induced toxicity in the heart, brain, liver, and other organs and tissues. The accumulated knowledge in these areas requires research aimed at clarifying open questions.

This Special Issue is focused on the molecular and cellular mechanisms leading to mitochondrial disorders, with particular attention to molecules involved in the regulation of mitochondrial dynamics, biogenesis, and mitophagy. Especially, studies employing novel therapeutic approaches targeting mitochondria and redox dyshomeostasis to improve treatment outcomes will be given priority. Additionally, research papers and review articles exploring the effects of mitochondrial therapy on cell pathologies will also be included.

Prof. Dr. Konstantin Belosludtsev
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mitochondria
  • mitochondrial DNA
  • mitochondrial dynamics
  • mitophagy
  • mitochondrial toxicity
  • apoptosis
  • primary mitochondrial disease
  • secondary mitochondrial dysfunction
  • mitochondria-targeted drug discovery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 1603 KiB  
Communication
Alterations in Mitochondrial Morphology and Quality Control in Primary Mouse Lung Microvascular Endothelial Cells and Human Dermal Fibroblasts under Hyperglycemic Conditions
by Natalia V. Belosludtseva, Dmitriy A. Serov, Vlada S. Starinets, Nikita V. Penkov and Konstantin N. Belosludtsev
Int. J. Mol. Sci. 2023, 24(15), 12485; https://doi.org/10.3390/ijms241512485 - 6 Aug 2023
Cited by 2 | Viewed by 1625
Abstract
The effect of hyperglycemia on the morphology of individual mitochondria and the state of the mitochondrial network in primary mouse lung microvascular endotheliocytes and human dermal fibroblasts has been investigated. The cells were exposed to high (30 mM) and low (5.5 mM) glucose [...] Read more.
The effect of hyperglycemia on the morphology of individual mitochondria and the state of the mitochondrial network in primary mouse lung microvascular endotheliocytes and human dermal fibroblasts has been investigated. The cells were exposed to high (30 mM) and low (5.5 mM) glucose concentrations for 36 h. In primary endotheliocytes, hyperglycemic stress induced a significant increase in the number of mitochondria and a decrease in the interconnectivity value of the mitochondrial network, which was associated with a decrease in the mean size of the mitochondria. Analysis of the mRNA level of the genes of proteins responsible for mitochondrial biogenesis and mitophagy revealed an increase in the expression level of the Ppargc1a, Pink1, and Parkin genes, indicating stimulated mitochondrial turnover in endotheliocytes under high glucose conditions. In primary fibroblasts, hyperglycemia caused a decrease in the number of mitochondria and an increase in their size. As a result, the mitochondria exhibited higher values for elongation. In parallel, the mRNA level of the Ppargc1a and Mfn2 genes in fibroblasts exposed to hyperglycemia was reduced. These findings indicate that high glucose concentrations induced cell-specific morphological rearrangements of individual mitochondria and the mitochondrial network, which may be relevant during mitochondria-targeted drug testing and therapy for hyperglycemic and diabetic conditions. Full article
(This article belongs to the Special Issue Primary Mitochondrial Diseases and Secondary Mitochondrial Dysfunction: New Insights and Therapies)
►▼ Show Figures

Figure 1

Review

Jump to: Research

24 pages, 1356 KiB  
Review
Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis
by Natalia V. Belosludtseva, Lyudmila A. Matveeva and Konstantin N. Belosludtsev
Int. J. Mol. Sci. 2023, 24(23), 16833; https://doi.org/10.3390/ijms242316833 - 27 Nov 2023
Cited by 11 | Viewed by 2155
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal multisystem disease characterized by progressive death of motor neurons, loss of muscle mass, and impaired energy metabolism. More than 40 genes are now known to be associated with ALS, which together account for the majority of [...] Read more.
Amyotrophic lateral sclerosis (ALS) is a fatal multisystem disease characterized by progressive death of motor neurons, loss of muscle mass, and impaired energy metabolism. More than 40 genes are now known to be associated with ALS, which together account for the majority of familial forms of ALS and only 10% of sporadic ALS cases. To date, there is no consensus on the pathogenesis of ALS, which makes it difficult to develop effective therapy. Accumulating evidence indicates that mitochondria, which play an important role in cellular homeostasis, are the earliest targets in ALS, and abnormalities in their structure and functions contribute to the development of bioenergetic stress and disease progression. Mitochondria are known to be highly dynamic organelles, and their stability is maintained through a number of key regulatory pathways. Mitochondrial homeostasis is dynamically regulated via mitochondrial biogenesis, clearance, fission/fusion, and trafficking; however, the processes providing “quality control” and distribution of the organelles are prone to dysregulation in ALS. Here, we systematically summarized changes in mitochondrial turnover, dynamics, calcium homeostasis, and alterations in mitochondrial transport and functions to provide in-depth insights into disease progression pathways, which may have a significant impact on current symptomatic therapies and personalized treatment programs for patients with ALS. Full article
(This article belongs to the Special Issue Primary Mitochondrial Diseases and Secondary Mitochondrial Dysfunction: New Insights and Therapies)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop